--- Chain 10 for Question 102 ---
Status: USED_FOR_VOTING
Finish Reason (Model): stop
Extracted Answer: D
Prompt Tokens (Usage): 439
Completion Tokens (Usage): 3847
Reasoning Tokens (Counted): 3334
Non-Reasoning Tokens (Counted): 511
Total Tokens (Usage): 4286

--- Reasoning Content ---
Okay, so I'm trying to figure out this science question. Let's see, it's about a ligand-receptor pair expressed in neural crest cells and their developmental fate. The question is about why there's no green signal when they visualize the mice under the confocal.

So, first, the setup: they created a bicistronic lox-Cre vector. Bicistronic means it has two ORFs in one vector. The ligand's ORF is at the 5' end, fused to mCherry. The receptor's ORF is at the 3' end, fused to eGFP at the C-terminus. 

The ligand is under the CBA promoter, which I think is a strong promoter, maybe constitutively active? And between the ligand and mCherry is a stop cassette with loxP. Then, the receptor has an IRES upstream of it. IRES elements allow internal ribosome entry, so they can drive translation of the downstream ORF without the need for a new promoter. So, the receptor should be expressed after the IRES from whatever promoter is before it.

Wait, the ligand is under CBA, so the receptor would be under the IRES, which could be under the same promoter as the ligand. So the ligand and receptor should be co-expressed in the same cells, I suppose.

They have stop cassettes with lox sites. So, in the absence of Cre, the mCherry is only expressed when the ligand is expressed, and the eGFP is only expressed when the receptor is expressed. But when Cre is present, like in the presence of Cre, the stop cassettes would be removed.

Wait, the vector is bicistronic with lox sites. So in the absence of Cre, the ligand is expressed, but the mCherry is separated by a stop. So the ligand is expressed as a fusion with mCherry, but the receptor would be under the IRES, and perhaps the eGFP is under a stop until the IRES is active. Hmm, I'm not entirely sure about this part.

They transfected the plasmid into primary astrocyte culture and used Western blot to test expression. They used antibodies against the overexpressed proteins. So they expected to see both proteins expressed, but when they looked in the Western blot, everything was proportional to actin, so the loading was fine. So the problem isn't with the blot or the antibodies.

Now, the transgenic mouse model is homozygous for the construct in a wild-type background. Then they crossed it to SOX10-Cre hemizygous mice. SOX10 is a transcription factor important in neural crest development. So using SOX10-Cre would activate Cre in the neural crest cells, I think.

When the offspring are born, they visualize them under the confocal. They're looking for the eGFP signal, I guess, because the green signal comes from eGFP. But they see no green. So why?

Looking at the options:

Option A: ligand and receptor are in a paracrine relationship. Paracrine means they act on nearby cells. But the construct would express both ligand and receptor in the same cells, so it's an autocrine or perhaps paracrine, but I'm not sure how that affects the expression of the fluorophores. But the problem is that eGFP isn't expressed, so maybe this isn't directly the reason.

Option B: the receptor-eGFP construct is stuck in the Golgi. If it's stuck, the GFP wouldn't be on the cell surface, so wouldn't fluoresce. But if it's in the Golgi, maybe it's retained there. But then in the Western blot, would they detect it? Because Western blot uses total proteins, so even if it's stuck in the ER or Golgi, the protein would still be present. So the Western blot showed the proteins were expressed; so this might not be the issue.

Option C: the enhancer for the ligand and receptor expression is missing. The construct has the ligand under CBA, which is a strong promoter. The receptor is under the IRES, so it's probably under the same promoter as the ligand. So if the enhancer was missing, maybe expression is low, but the Western blot showed they were expressed. So I'm not sure. Unless the CBA promoter doesn't include an enhancer, but I think CBA is a strong promoter.

Option D: the receptor and eGFP are not in the frame. So the ORF for the receptor is fused to eGFP, but if they're not in frame, the eGFP wouldn't be expressed. Wait, the vector has the receptor ORF at 3' with eGFP at C-terminus. If the stop cassette is after the receptor, and the eGFP is in the same ORF as the receptor, then the eGFP would be a fusion. Wait, no. Wait, the vector is bicistronic. So the first ORF is ligand-mCherry, with a stop. The second ORF is receptor-eGFP, but how is it arranged? Let me think. The vector is designed so that in the absence of Cre, the ligand is expressed, but the mCherry is blocked by a stop, so only ligand-mCherry is expressed. Similarly, the receptor might be under a stop until the IRES, perhaps.

Wait, maybe the vector is designed such that the ligand and mCherry are in the same ORF, separated by a stop. Then the IRES allows the receptor to be expressed, perhaps as a separate ORF, with eGFP. But if the eGFP is in frame, then when Cre is present, both ligand and receptor would be expressed, but without the fluorescent proteins. Or wait, perhaps the stop cassettes are in such a way that when Cre is present, the stop is removed, allowing the expression of the fluorescent proteins.

Wait, the ligand is at 5', and behind it is a stop cassette with loxP. The receptor is at 3', before eGFP, which has a stop with lox2272.

So, without Cre, the ligand is expressed as a fusion with mCherry. The receptor is expressed as a fusion with eGFP? Or is it the other way around.

Wait, the vector is a bicistronic construct. So the first cistron is the ligand (under CBA promoter), with a stop with loxP. The second cistron is the receptor, which is after an IRES. The IRES is a ribosome binding site, so it's for internal initiation. So the receptor would be expressed as its own ORF, but after the IRES.

Wait, the question says the ligand is under the CBA promoter, and upstream of the receptor is the IRES regulatory element. So the promoter is for the ligand, and the receptor is expressed via IRES.

Wait, perhaps it's arranged like this:

Promoter -> Ligand ORF -> loxP-stop-loxP -> mCherry

Then, IRES -> Receptor ORF -> lox2272-stop-lox2272 -> eGFP

So, in the absence of Cre, the ligand ORF is expressed (because promoter is active), but the mCherry is blocked by the stop cassette. The receptor would be under the IRES, which is after the ligand ORF. So the IRES would allow the ribosome to translate the receptor ORF, but then the eGFP is blocked by another stop cassette. So in the absence of Cre, the cells would express the ligand and the receptor, but without the fluorescent tags.

But they used Western blot with antibodies against the overexpressed proteins, so they saw the proteins expressed. So the construct works in that sense.

When you add Cre, the stop cassettes would be removed. So the ligand-mCherry fusion would be expressed, and the receptor-eGFP fusion. So in Cre-expressing cells, both fluorescent proteins would be expressed.

But in the experiment, they crossed the homozygous mice with SOX10-Cre. SOX10-Cre would express Cre in neural crest cells, which are the cells expressing the ligand and receptor.

So, in the offspring, in the neural crest cells, Cre should remove the stop cassettes, allowing the expression of ligand-mCherry and receptor-eGFP.

But in the confocal, no green signal (eGFP) is observed. So why is eGFP not expressed?

Looking at the options again.

Option D: the receptor and eGFP are not in frame. Wait, if the stop cassette is in front of the eGFP, but the stop is lox2272, and Cre is present, then the stop should be removed. If the eGFP is in the same frame as the receptor, it should be a fusion. But if the ORF is not in frame, the eGFP might not be expressed. For example, in the absence of the stop, the receptor might be followed by eGFP, but if the frames don't match, the eGFP won't be translated. So the construct might have a frame shift, making the eGFP not produce a functional protein. So no eGFP would be detected.

But wait, the Western blot uses antibodies against the overexpressed proteins. They probably used separate antibodies for ligand and receptor. Suppose the eGFP is part of the receptor construct. So if the receptor is expressed, but eGFP isn't, perhaps the antibody is against the receptor and they see it on the blot. If the eGFP is not in frame, the receptor might be expressed but eGFP isn't. But in the confocal, they're looking for eGFP. So if eGFP isn't expressed, they wouldn't see the green signal.

Alternatively, perhaps the IRES is not correctly placed. Or the eGFP is placed after the stop cassette, and Cre wasn't able to remove it, but that's unlikely because the question says they used SOX10-Cre.

Another possibility is that the IRES is not functioning, so the receptor isn't expressed. But the Western blot showed the proteins were expressed, which would mean the IRES worked.

Wait, maybe the eGFP is not in frame, so it's not expressed. So option D is the correct answer.

Alternatively, the problem is that the eGFP isn't being expressed because the stop cassette isn't properly removed.

Wait, in the vector, the ligand is at 5', with a stop, and the receptor is at 3', with another stop. The IRES is upstream of the receptor. So when Cre is present, it would remove the stops, allowing the ligand to be expressed as ligand-mCherry, and the receptor to be expressed as receptor-eGFP.

But perhaps the lox sites are in the wrong configuration. For example, the loxP sites for the stop cassette in the ligand region and the lox2272 sites in the receptor region. Cre can only recognize loxP sites, not lox2272. Wait, no, Cre is a recombinase that recognizes loxP sites, but lox2272 is a variant that is Cre-dependent but has a different arrangement.

Wait, in the ligand region, it's a loxP-stop-loxP cassette. So Cre would remove this, allowing the mCherry to be expressed after the ligand. For the receptor, the stop is in a lox2272 cassette. Lox2272 is a mutant lox site that can't be recognized by Cre without another site. Or perhaps the lox2272 is a site that requires a different recombinase.

Wait, lox2272 is a variant of the loxP site that is recognized by Cre but only in the presence of another lox site nearby. Alternatively, lox2272 is a site that is used for 'flip' recombination—so Cre can mediate recombination between loxP and lox2272 sites, but only in a certain configuration.

Wait, I'm getting a bit confused. Let me think. The loxP site is recognized by Cre and causes recombination between two loxP sites, deleting the intervening region. Lox2272 is a mutated version that can't function as a loxP site for Cre. Instead, Cre can cause recombination between a loxP and a lox2272 site, but only if they are in a specific orientation. Alternatively, perhaps the stop cassette in the receptor is flanked by lox2272 sites, which Cre cannot recognize, but I'm not sure.

Wait, if the receptor's stop cassette is flanked by lox2272 sites, then Cre (which only recognizes loxP) wouldn't cut there. So the stop cassette wouldn't be removed, meaning the eGFP wouldn't be expressed. So the eGFP wouldn't be present, leading to no green signal.

But the question says that the ligand's stop is flanked by loxP sites and the receptor's by lox2272. So if Cre is expressed, it would remove the ligand's stop, allowing mCherry to be expressed. But for the receptor, the lox2272 sites can't be cut by Cre, so the stop remains. Thus, the eGFP wouldn't be expressed, so no green.

But wait, the vector is designed so that the stop cassettes are flanked by different lox sites. So when Cre is present, it would remove the loxP stops but not the lox2272 stops. So in the ligand region, the stop would be removed, allowing mCherry expression. But in the receptor region, the stop would remain because Cre can't cut lox2272. So the eGFP would not be expressed.

So that's why there's no green signal. But looking at the options, none of them directly say that the stop wasn't removed due to the wrong lox sites. So looking back at the options, the correct reason is D: the receptor and eGFP are not in frame. Or is it something else?

Wait, another possibility: the IRES is not working, so the receptor isn't expressed. But the Western blot would have shown the receptor is expressed, so that can't be.

Alternatively, the enhancer is missing, so the promoter isn't active. But the promoter is CBA, which is strong, so I don't think that's the case.

Wait, perhaps the problem is that the eGFP is not in the same reading frame as the receptor. If the stop cassette is removed, the receptor's ORF continues into eGFP, but if they're not in frame, eGFP isn't expressed. So the eGFP would be a frameshift, and not translated. Hence, no GFP.

So looking at the options, option D says, "the receptor and the eGFP are not in the frame." So that would explain why eGFP isn't expressed, even though Cre is present and the stop is removed.

Alternatively, maybe the stop cassette wasn't removed because the lox sites were wrong, but the options don't mention that. The options given are A to D.

So the most likely reason is D: the receptor and eGFP are not in the frame. So when the stop is removed, the receptor is followed by eGFP in the same ORF, but if they're not in frame, the eGFP isn't expressed.


--- Final Answer Content ---


The question involves a bicistronic lox-Cre vector expressing a ligand and receptor in neural crest cells. The ligand is under the CBA promoter, with a loxP-stop-loxP cassette upstream of mCherry, and the receptor is under an IRES, with a lox2272-stop-lox2272 cassette upstream of eGFP. The construct was transfected into primary astrocyte culture, and Western blot confirmed expression of the ligand and receptor. However, when the mice were crossed with SOX10-Cre hemizygous mice, no green signal (eGFP) was observed under confocal microscopy.

### Key Analysis of the Options:
1. **Option A (Ligand and receptor in a paracrine relationship):**  
   Paracrine interactions involve signaling between nearby cells, but the construct is designed to co-express the ligand and receptor in the same cells (autocrine signaling). This does not explain the lack of eGFP expression.

2. **Option B (Receptor-eGFP construct stuck in the Golgi):**  
   If the receptor-eGFP were stuck in the Golgi, it would still be detectable in Western blot, as total proteins were loaded and actin levels were proportional. Since the Western blot confirmed receptor expression, this is unlikely to be the reason.

3. **Option C (Enhancer for ligand and receptor expression is missing):**  
   The ligand is under the CBA promoter, which is strong and constitutively active. The receptor is under the IRES, which should allow its expression. The Western blot confirmed expression of both proteins, so the absence of an enhancer is unlikely to be the issue.

4. **Option D (Receptor and eGFP are not in the frame):**  
   The vector is designed such that the stop cassettes are removed by Cre, allowing expression of the ligand-mCherry and receptor-eGFP fusions. However, if the receptor and eGFP are not in the same reading frame, the eGFP would not be translated, even if the stop cassette is removed. This would explain the lack of green signal under confocal microscopy.

### Conclusion:
The most likely explanation is that the receptor and eGFP are not in the same reading frame, preventing eGFP expression. This aligns with the observed absence of the green signal in the confocal microscopy.

Answer: D

--- Full Content ---
Okay, so I'm trying to figure out this science question. Let's see, it's about a ligand-receptor pair expressed in neural crest cells and their developmental fate. The question is about why there's no green signal when they visualize the mice under the confocal.

So, first, the setup: they created a bicistronic lox-Cre vector. Bicistronic means it has two ORFs in one vector. The ligand's ORF is at the 5' end, fused to mCherry. The receptor's ORF is at the 3' end, fused to eGFP at the C-terminus. 

The ligand is under the CBA promoter, which I think is a strong promoter, maybe constitutively active? And between the ligand and mCherry is a stop cassette with loxP. Then, the receptor has an IRES upstream of it. IRES elements allow internal ribosome entry, so they can drive translation of the downstream ORF without the need for a new promoter. So, the receptor should be expressed after the IRES from whatever promoter is before it.

Wait, the ligand is under CBA, so the receptor would be under the IRES, which could be under the same promoter as the ligand. So the ligand and receptor should be co-expressed in the same cells, I suppose.

They have stop cassettes with lox sites. So, in the absence of Cre, the mCherry is only expressed when the ligand is expressed, and the eGFP is only expressed when the receptor is expressed. But when Cre is present, like in the presence of Cre, the stop cassettes would be removed.

Wait, the vector is bicistronic with lox sites. So in the absence of Cre, the ligand is expressed, but the mCherry is separated by a stop. So the ligand is expressed as a fusion with mCherry, but the receptor would be under the IRES, and perhaps the eGFP is under a stop until the IRES is active. Hmm, I'm not entirely sure about this part.

They transfected the plasmid into primary astrocyte culture and used Western blot to test expression. They used antibodies against the overexpressed proteins. So they expected to see both proteins expressed, but when they looked in the Western blot, everything was proportional to actin, so the loading was fine. So the problem isn't with the blot or the antibodies.

Now, the transgenic mouse model is homozygous for the construct in a wild-type background. Then they crossed it to SOX10-Cre hemizygous mice. SOX10 is a transcription factor important in neural crest development. So using SOX10-Cre would activate Cre in the neural crest cells, I think.

When the offspring are born, they visualize them under the confocal. They're looking for the eGFP signal, I guess, because the green signal comes from eGFP. But they see no green. So why?

Looking at the options:

Option A: ligand and receptor are in a paracrine relationship. Paracrine means they act on nearby cells. But the construct would express both ligand and receptor in the same cells, so it's an autocrine or perhaps paracrine, but I'm not sure how that affects the expression of the fluorophores. But the problem is that eGFP isn't expressed, so maybe this isn't directly the reason.

Option B: the receptor-eGFP construct is stuck in the Golgi. If it's stuck, the GFP wouldn't be on the cell surface, so wouldn't fluoresce. But if it's in the Golgi, maybe it's retained there. But then in the Western blot, would they detect it? Because Western blot uses total proteins, so even if it's stuck in the ER or Golgi, the protein would still be present. So the Western blot showed the proteins were expressed; so this might not be the issue.

Option C: the enhancer for the ligand and receptor expression is missing. The construct has the ligand under CBA, which is a strong promoter. The receptor is under the IRES, so it's probably under the same promoter as the ligand. So if the enhancer was missing, maybe expression is low, but the Western blot showed they were expressed. So I'm not sure. Unless the CBA promoter doesn't include an enhancer, but I think CBA is a strong promoter.

Option D: the receptor and eGFP are not in the frame. So the ORF for the receptor is fused to eGFP, but if they're not in frame, the eGFP wouldn't be expressed. Wait, the vector has the receptor ORF at 3' with eGFP at C-terminus. If the stop cassette is after the receptor, and the eGFP is in the same ORF as the receptor, then the eGFP would be a fusion. Wait, no. Wait, the vector is bicistronic. So the first ORF is ligand-mCherry, with a stop. The second ORF is receptor-eGFP, but how is it arranged? Let me think. The vector is designed so that in the absence of Cre, the ligand is expressed, but the mCherry is blocked by a stop, so only ligand-mCherry is expressed. Similarly, the receptor might be under a stop until the IRES, perhaps.

Wait, maybe the vector is designed such that the ligand and mCherry are in the same ORF, separated by a stop. Then the IRES allows the receptor to be expressed, perhaps as a separate ORF, with eGFP. But if the eGFP is in frame, then when Cre is present, both ligand and receptor would be expressed, but without the fluorescent proteins. Or wait, perhaps the stop cassettes are in such a way that when Cre is present, the stop is removed, allowing the expression of the fluorescent proteins.

Wait, the ligand is at 5', and behind it is a stop cassette with loxP. The receptor is at 3', before eGFP, which has a stop with lox2272.

So, without Cre, the ligand is expressed as a fusion with mCherry. The receptor is expressed as a fusion with eGFP? Or is it the other way around.

Wait, the vector is a bicistronic construct. So the first cistron is the ligand (under CBA promoter), with a stop with loxP. The second cistron is the receptor, which is after an IRES. The IRES is a ribosome binding site, so it's for internal initiation. So the receptor would be expressed as its own ORF, but after the IRES.

Wait, the question says the ligand is under the CBA promoter, and upstream of the receptor is the IRES regulatory element. So the promoter is for the ligand, and the receptor is expressed via IRES.

Wait, perhaps it's arranged like this:

Promoter -> Ligand ORF -> loxP-stop-loxP -> mCherry

Then, IRES -> Receptor ORF -> lox2272-stop-lox2272 -> eGFP

So, in the absence of Cre, the ligand ORF is expressed (because promoter is active), but the mCherry is blocked by the stop cassette. The receptor would be under the IRES, which is after the ligand ORF. So the IRES would allow the ribosome to translate the receptor ORF, but then the eGFP is blocked by another stop cassette. So in the absence of Cre, the cells would express the ligand and the receptor, but without the fluorescent tags.

But they used Western blot with antibodies against the overexpressed proteins, so they saw the proteins expressed. So the construct works in that sense.

When you add Cre, the stop cassettes would be removed. So the ligand-mCherry fusion would be expressed, and the receptor-eGFP fusion. So in Cre-expressing cells, both fluorescent proteins would be expressed.

But in the experiment, they crossed the homozygous mice with SOX10-Cre. SOX10-Cre would express Cre in neural crest cells, which are the cells expressing the ligand and receptor.

So, in the offspring, in the neural crest cells, Cre should remove the stop cassettes, allowing the expression of ligand-mCherry and receptor-eGFP.

But in the confocal, no green signal (eGFP) is observed. So why is eGFP not expressed?

Looking at the options again.

Option D: the receptor and eGFP are not in frame. Wait, if the stop cassette is in front of the eGFP, but the stop is lox2272, and Cre is present, then the stop should be removed. If the eGFP is in the same frame as the receptor, it should be a fusion. But if the ORF is not in frame, the eGFP might not be expressed. For example, in the absence of the stop, the receptor might be followed by eGFP, but if the frames don't match, the eGFP won't be translated. So the construct might have a frame shift, making the eGFP not produce a functional protein. So no eGFP would be detected.

But wait, the Western blot uses antibodies against the overexpressed proteins. They probably used separate antibodies for ligand and receptor. Suppose the eGFP is part of the receptor construct. So if the receptor is expressed, but eGFP isn't, perhaps the antibody is against the receptor and they see it on the blot. If the eGFP is not in frame, the receptor might be expressed but eGFP isn't. But in the confocal, they're looking for eGFP. So if eGFP isn't expressed, they wouldn't see the green signal.

Alternatively, perhaps the IRES is not correctly placed. Or the eGFP is placed after the stop cassette, and Cre wasn't able to remove it, but that's unlikely because the question says they used SOX10-Cre.

Another possibility is that the IRES is not functioning, so the receptor isn't expressed. But the Western blot showed the proteins were expressed, which would mean the IRES worked.

Wait, maybe the eGFP is not in frame, so it's not expressed. So option D is the correct answer.

Alternatively, the problem is that the eGFP isn't being expressed because the stop cassette isn't properly removed.

Wait, in the vector, the ligand is at 5', with a stop, and the receptor is at 3', with another stop. The IRES is upstream of the receptor. So when Cre is present, it would remove the stops, allowing the ligand to be expressed as ligand-mCherry, and the receptor to be expressed as receptor-eGFP.

But perhaps the lox sites are in the wrong configuration. For example, the loxP sites for the stop cassette in the ligand region and the lox2272 sites in the receptor region. Cre can only recognize loxP sites, not lox2272. Wait, no, Cre is a recombinase that recognizes loxP sites, but lox2272 is a variant that is Cre-dependent but has a different arrangement.

Wait, in the ligand region, it's a loxP-stop-loxP cassette. So Cre would remove this, allowing the mCherry to be expressed after the ligand. For the receptor, the stop is in a lox2272 cassette. Lox2272 is a mutant lox site that can't be recognized by Cre without another site. Or perhaps the lox2272 is a site that requires a different recombinase.

Wait, lox2272 is a variant of the loxP site that is recognized by Cre but only in the presence of another lox site nearby. Alternatively, lox2272 is a site that is used for 'flip' recombination—so Cre can mediate recombination between loxP and lox2272 sites, but only in a certain configuration.

Wait, I'm getting a bit confused. Let me think. The loxP site is recognized by Cre and causes recombination between two loxP sites, deleting the intervening region. Lox2272 is a mutated version that can't function as a loxP site for Cre. Instead, Cre can cause recombination between a loxP and a lox2272 site, but only if they are in a specific orientation. Alternatively, perhaps the stop cassette in the receptor is flanked by lox2272 sites, which Cre cannot recognize, but I'm not sure.

Wait, if the receptor's stop cassette is flanked by lox2272 sites, then Cre (which only recognizes loxP) wouldn't cut there. So the stop cassette wouldn't be removed, meaning the eGFP wouldn't be expressed. So the eGFP wouldn't be present, leading to no green signal.

But the question says that the ligand's stop is flanked by loxP sites and the receptor's by lox2272. So if Cre is expressed, it would remove the ligand's stop, allowing mCherry to be expressed. But for the receptor, the lox2272 sites can't be cut by Cre, so the stop remains. Thus, the eGFP wouldn't be expressed, so no green.

But wait, the vector is designed so that the stop cassettes are flanked by different lox sites. So when Cre is present, it would remove the loxP stops but not the lox2272 stops. So in the ligand region, the stop would be removed, allowing mCherry expression. But in the receptor region, the stop would remain because Cre can't cut lox2272. So the eGFP would not be expressed.

So that's why there's no green signal. But looking at the options, none of them directly say that the stop wasn't removed due to the wrong lox sites. So looking back at the options, the correct reason is D: the receptor and eGFP are not in frame. Or is it something else?

Wait, another possibility: the IRES is not working, so the receptor isn't expressed. But the Western blot would have shown the receptor is expressed, so that can't be.

Alternatively, the enhancer is missing, so the promoter isn't active. But the promoter is CBA, which is strong, so I don't think that's the case.

Wait, perhaps the problem is that the eGFP is not in the same reading frame as the receptor. If the stop cassette is removed, the receptor's ORF continues into eGFP, but if they're not in frame, eGFP isn't expressed. So the eGFP would be a frameshift, and not translated. Hence, no GFP.

So looking at the options, option D says, "the receptor and the eGFP are not in the frame." So that would explain why eGFP isn't expressed, even though Cre is present and the stop is removed.

Alternatively, maybe the stop cassette wasn't removed because the lox sites were wrong, but the options don't mention that. The options given are A to D.

So the most likely reason is D: the receptor and eGFP are not in the frame. So when the stop is removed, the receptor is followed by eGFP in the same ORF, but if they're not in frame, the eGFP isn't expressed.


The question involves a bicistronic lox-Cre vector expressing a ligand and receptor in neural crest cells. The ligand is under the CBA promoter, with a loxP-stop-loxP cassette upstream of mCherry, and the receptor is under an IRES, with a lox2272-stop-lox2272 cassette upstream of eGFP. The construct was transfected into primary astrocyte culture, and Western blot confirmed expression of the ligand and receptor. However, when the mice were crossed with SOX10-Cre hemizygous mice, no green signal (eGFP) was observed under confocal microscopy.

### Key Analysis of the Options:
1. **Option A (Ligand and receptor in a paracrine relationship):**  
   Paracrine interactions involve signaling between nearby cells, but the construct is designed to co-express the ligand and receptor in the same cells (autocrine signaling). This does not explain the lack of eGFP expression.

2. **Option B (Receptor-eGFP construct stuck in the Golgi):**  
   If the receptor-eGFP were stuck in the Golgi, it would still be detectable in Western blot, as total proteins were loaded and actin levels were proportional. Since the Western blot confirmed receptor expression, this is unlikely to be the reason.

3. **Option C (Enhancer for ligand and receptor expression is missing):**  
   The ligand is under the CBA promoter, which is strong and constitutively active. The receptor is under the IRES, which should allow its expression. The Western blot confirmed expression of both proteins, so the absence of an enhancer is unlikely to be the issue.

4. **Option D (Receptor and eGFP are not in the frame):**  
   The vector is designed such that the stop cassettes are removed by Cre, allowing expression of the ligand-mCherry and receptor-eGFP fusions. However, if the receptor and eGFP are not in the same reading frame, the eGFP would not be translated, even if the stop cassette is removed. This would explain the lack of green signal under confocal microscopy.

### Conclusion:
The most likely explanation is that the receptor and eGFP are not in the same reading frame, preventing eGFP expression. This aligns with the observed absence of the green signal in the confocal microscopy.

Answer: D